Investigation of human papilloma virus frequency in pregnant women.
cervical cancer
human papilloma virus
pregnant women
Journal
The journal of obstetrics and gynaecology research
ISSN: 1447-0756
Titre abrégé: J Obstet Gynaecol Res
Pays: Australia
ID NLM: 9612761
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
06
04
2023
accepted:
13
08
2023
medline:
6
11
2023
pubmed:
24
8
2023
entrez:
23
8
2023
Statut:
ppublish
Résumé
The aim of this study was to determine the frequency of human papillomavirus (HPV), HPV types, and the association with age, pregnancy, and childbirth in pregnant women. Four hundred and forty-eight pregnant women who visited our clinic were enrolled in the study. Polymerase chain reaction was used to determine HPV DNA and typing by cervical smear in the initial applications of patients with detailed history. Statistical Package for the Social Sciences (SPSS) 13.0 was used to analyze the data. HPV DNA was positive in 26 (5.8%) of 448 patients who participated in the study. High-risk HPV types were detected in 77% of HPV-positive cases and low-risk HPV types in 23% of cases. Only one HPV type was detected in 13 patients (50%), while multiple HPV types were detected in 13 patients (50%) of the HPV-positive cases. A significant negative association was found between gravidity and positivity of HPV DNA. HPV is more common in women with lower parity and gravidity. Studies conducted in different populations in different regions of Turkey have shown that the incidence of HPV in women ranges from 2.2% to 26%. In our study, the incidence of HPV DNA in pregnant women was 5.8%. It was found that there was an inverse relationship between parity and HPV DNA positivity. The HPV DNA positivity decreased with the number of births.
Substances chimiques
DNA, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2728-2733Subventions
Organisme : Bülent Ecevit University Scientific Research Projects Coordination
Informations de copyright
© 2023 Japan Society of Obstetrics and Gynecology.
Références
Tessema D, Kassu A, Teshome A, Abdo R. Timely initiation of antenatal care and associated factors among pregnant women attending at Wachemo University Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital, Hossana, Ethiopia: a cross-sectional study. J Pregnancy. 2023;2023:7054381. https://doi.org/10.1155/2023/7054381
Kassaw A, Debie A, Geberu DM. Quality of prenatal care and associated factors among pregnant women at public health facilities of Wogera District Northwest Ethiopia. J Pregnancy. 2020;29(2020):1-8. https://doi.org/10.1155/2020/9592124
Hagensee M. Seroprevalence of human papillomavirus type 16 in pregnant women. Obstet Gynecol. 1999;94(5):653-658. https://doi.org/10.1016/s0029-7844(99)00454-8
Ayhan A, Dursun P, Gültekin M, Taşkıran Ç. Jinekolojik onkoloji. 2nd ed. Ankara: Güneş Tıp Bookstore; 2013. p. 25.
Gultekin M, Zayifoglu Karaca M, Kucukyildiz I, Dundar S, Boztas G, Semra Turan H, et al. Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women: Turkish cervical cancer screening program. Int J Cancer. 2018;142(9):1952-1958. https://doi.org/10.1002/ijc.31212
Sampson JE, Gravett MG. Other infectious conditions in pregnancy: James DK. In: Steer PJ, Weiner CP, Govik B, editors. High risk pregnancy, management options. 2nd ed. London: WB Saunders; 1999.
Eppel W. Human papillomavirus in the cervix and placenta. Obstet Gynecol. 2000;96(3):337-341. https://doi.org/10.1016/s0029-7844(00)00953-4
Armbruster-Moraes E, Ioshimoto LM, Leão E, Zugaib M. Presence of human papillomavirus DNA in amniotic fluids of pregnant women with cervical lesions. Gynecol Oncol. 1994;54(2):152-158. https://doi.org/10.1006/gyno.1994.1185
Chan PKS, Chang AR, Tam WH, Cheung JLK, Cheng AF. Prevalence and genotype distribution of cervical human papillomavirus infection: comparison between pregnant women and non-pregnant controls. J Med Virol. 2002;67(4):583-588. https://doi.org/10.1002/jmv.10142
Puranen M, Yliskoski M, Saarikoski S, Syrjänen K, Syrjänen S. Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol. 1996;174(2):694-699. https://doi.org/10.1016/s0002-9378(96)70452-0
Tseng CJ, Liang CC, Soong YK, Pao CC. Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery. Obstet Gynecol. 1998;91(1):92-96. https://doi.org/10.1016/s0029-7844(97)00593-0
Rintala MAM, Grenman SE, Puranen MH, Isolauri E, Ekblad U, Kero PO. Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. J Clin Microbiol. 2005;43(1):376-381. https://doi.org/10.1128/JCM.43.1.376-381.2005
Alacam S, Bakir A. Human papillomavirus prevalence and genotype distribution in cervical swab samples in Istanbul, Turkey. J Infect Dev Ctries. 2021;15(8):1190-1196. https://doi.org/10.3855/jidc.14663
Aydogdu G. Distribución de la prevalencia del virus del papiloma humano, genotipo y resultados de la prueba de PAP en mujeres del sureste de Turquía. Cir Cir. 2023;91(3):319-325. https://doi.org/10.24875/CIRU.22000400
Aydin Y, Atis A, Tutuman T, Goker N. Prevalence of human papilloma virus infection in pregnant Turkish women compared with non-pregnant women. Eur J Gynaecol Oncol. 2010;31(1):72-74.
Castellsagué X, Drudis T, Cañadas MP, Goncé A, Ros R, Pérez JM, et al. Human papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain. BMC Infect Dis. 2009;9(1):74. https://doi.org/10.1186/1471-2334-9-74
Banura C, Franceschi S, Van Doorn LJ, Arslan A, Kleter B, Wabwire-Mangen F, et al. Prevalence, incidence and clearance of human papillomavirus infection among young primiparous pregnant women in Kampala, Uganda. Int J Cancer. 2008;123(9):2180-2187. https://doi.org/10.1002/ijc.23762
Domža G, Gudlevičienė Ž, Didžiapetrienė J, Valuckas KP, Kazbarienė B, Drąsutienė G. Human papillomavirus infection in pregnant women. Arch Gynecol Obstet. 2011;284(5):1105-1112. https://doi.org/10.1007/s00404-010-1787-4
Smith EM, Ritchie JM, Yankowitz J, Wang D, Turek LP, Haugen TH. HPV prevalence and concordance in the cervix and Oral cavity of pregnant women. Infect Dis Obstet Gynecol. 2004;12(1):45-56. https://doi.org/10.1080/10647440400009896
Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis. 1996;23(4):333-341. https://doi.org/10.1097/00007435-199607000-00013
De Villez RL, Stevens JS. Bowenoid papulosis of the genitalia. A case progressing to Bowen's disease. J Am Acad Dermatol. 1980;3(2):149-152. https://doi.org/10.1016/s0190-9622(80)80252-0
De Vuyst H, Steyaert S, Van Renterghem L, Claeys P, Muchiri L, Sitati S, et al. Distribution of human papillomavirus in a family planning population in Nairobi, Kenya. Sex Transm Dis. 2003;30(2):137-142. https://doi.org/10.1097/00007435-200302000-00009
Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004;364(9447):1757-1765. https://doi.org/10.1016/S0140-6736(04)17398-4
Tarkowski TA, Koumans EH, Sawyer M, Pierce A, Black CM, Papp JR, et al. Epidemiology of human papillomavirus infection and abnormal Cytologic test results in an urban adolescent population. J Infect Dis. 2004;189(1):46-50. https://doi.org/10.1086/380466
Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. Jama. 2007;297(8):813. https://doi.org/10.1001/jama.297.8.813
Takakuwa K, Mitsui T, Iwashita M, Kobayashi I, Suzuki A, Oda T, et al. Studies on the prevalence of human papillomavirus in pregnant women in Japan. J Perinat Med. 2006;34(1):77-79. https://doi.org/10.1515/JPM.2006.010
Morales-Peza N, Auewarakul P, Juárez V, Garcı́a-Carrancá A, Cid-Arregui A. In vivo tissue-specific regulation of the human papillomavirus type 18 early promoter by estrogen, progesterone, and their antagonists. Virology. 2002;294(1):135-140. https://doi.org/10.1006/viro.2001.1287
Rombaldi RL, Serafini EP, Mandelli J, Zimmermann E, Losquiavo KP. Perinatal transmission of human papilomavirus DNA. Virol J. 2009;6(1):83. https://doi.org/10.1186/1743-422X-5-106
Lu DW, Pirog EC, Zhu X, Wang HL, Pinto KR. Prevalence and typing of HPV DNA in atypical squamous cells in pregnant women. Acta Cytol. 2003;47(6):1008-1016. https://doi.org/10.1159/000326637
Hernández-Girón C, Smith JS, Lorincz A, Lazcano E, Hernández-Ávila M, Salmerón J. High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico. Sex Transm Dis. 2005;32(10):613-618. https://doi.org/10.1097/01.olq.0000179888.47309.db
Thomas KK, Hughes JP, Kuypers JM, Kiviat NB, Lee SK, Adam DE, et al. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis. 2000;182(4):1097-1102. https://doi.org/10.1086/315805
De Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz N, et al. Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis. 2003;30(10):788-793. https://doi.org/10.1097/01.OLQ.0000080177.82204.E0
Matos E, Loria D, Amestoy GM, Herrera L, Prince MA, Moreno J, et al. Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis. 2003;30(8):593-599. https://doi.org/10.1097/01.OLQ.0000085181.25063.6C
Tuncer S, Başaran M, Ustaçelebi Ş, Mocan-Kuzey G. High-risk human papilloma virus (HPV) infection determined by hybrid capture II assay in a Turkish university hospital outpatient clinic. Gynecol Obstet Reprod Med. 2006;12(2):129-134.
Pereira CRN, Rosa MLG, Vasconcelos GALBM, Faria PCP, Cavalcanti SMB, Oliveira LHS. Human papillomavirus prevalence and predictors for cervical cancer among high-risk women from Rio de Janeiro, Brazil. Int J Gynecol Cancer. 2007;17(3):651-660. https://doi.org/10.1111/j.1525-1438.2007.00844.x